doxapram has been researched along with Cerebral Hemorrhage in 1 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Cerebral Hemorrhage: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.
Excerpt | Relevance | Reference |
---|---|---|
" There was a marked difference in the cumulative dosage and duration of doxapram therapy used for apnea of prematurity (total dose 2233 +/- 1927 mg vs 615 +/- 767 mg, P < ." | 7.71 | Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea. ( Demianczuk, N; Etches, PC; Robertson, CM; Sreenan, C, 2001) |
" There was a marked difference in the cumulative dosage and duration of doxapram therapy used for apnea of prematurity (total dose 2233 +/- 1927 mg vs 615 +/- 767 mg, P < ." | 3.71 | Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea. ( Demianczuk, N; Etches, PC; Robertson, CM; Sreenan, C, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sreenan, C | 1 |
Etches, PC | 1 |
Demianczuk, N | 1 |
Robertson, CM | 1 |
1 other study available for doxapram and Cerebral Hemorrhage
Article | Year |
---|---|
Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea.
Topics: Apnea; Case-Control Studies; Cerebral Hemorrhage; Child Development; Developmental Disabilities; Dox | 2001 |